These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Genetic testing in pheochromocytoma: increasing importance for clinical decision making. Bornstein SR; Gimenez-Roqueplo AP Ann N Y Acad Sci; 2006 Aug; 1073():94-103. PubMed ID: 17102076 [TBL] [Abstract][Full Text] [Related]
29. Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas. Dannenberg H; Komminoth P; Dinjens WN; Speel EJ; de Krijger RR Endocr Pathol; 2003; 14(4):329-50. PubMed ID: 14739490 [TBL] [Abstract][Full Text] [Related]
30. New insights into the genetics of familial chromaffin cell tumors. Koch CA; Vortmeyer AO; Zhuang Z; Brouwers FM; Pacak K Ann N Y Acad Sci; 2002 Sep; 970():11-28. PubMed ID: 12381538 [TBL] [Abstract][Full Text] [Related]
31. A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma. Buffet A; Venisse A; Nau V; Roncellin I; Boccio V; Le Pottier N; Boussion M; Travers C; Simian C; Burnichon N; Abermil N; Favier J; Jeunemaitre X; Gimenez-Roqueplo AP Horm Metab Res; 2012 May; 44(5):359-66. PubMed ID: 22517557 [TBL] [Abstract][Full Text] [Related]
32. Pheochromocytoma and functional paraganglioma syndrome: no longer the 10% tumor. Elder EE; Elder G; Larsson C J Surg Oncol; 2005 Mar; 89(3):193-201. PubMed ID: 15719371 [TBL] [Abstract][Full Text] [Related]
33. Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients. Erlic Z; Rybicki L; Peczkowska M; Golcher H; Kann PH; Brauckhoff M; Müssig K; Muresan M; Schäffler A; Reisch N; Schott M; Fassnacht M; Opocher G; Klose S; Fottner C; Forrer F; Plöckinger U; Petersenn S; Zabolotny D; Kollukch O; Yaremchuk S; Januszewicz A; Walz MK; Eng C; Neumann HP; Clin Cancer Res; 2009 Oct; 15(20):6378-85. PubMed ID: 19825962 [TBL] [Abstract][Full Text] [Related]
34. SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes. Pasini B; Stratakis CA J Intern Med; 2009 Jul; 266(1):19-42. PubMed ID: 19522823 [TBL] [Abstract][Full Text] [Related]
36. Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome. Erlic Z; Hoffmann MM; Sullivan M; Franke G; Peczkowska M; Harsch I; Schott M; Gabbert HE; Valimäki M; Preuss SF; Hasse-Lazar K; Waligorski D; Robledo M; Januszewicz A; Eng C; Neumann HP J Clin Endocrinol Metab; 2010 Jan; 95(1):308-13. PubMed ID: 19906784 [TBL] [Abstract][Full Text] [Related]
37. The clinical genetics of phaeochromocytoma and paraganglioma. Kavinga Gunawardane PT; Grossman A Arch Endocrinol Metab; 2017 Oct; 61(5):490-500. PubMed ID: 29166454 [TBL] [Abstract][Full Text] [Related]
38. [Current opinion in pathogenesis of pheochromocytoma]. Mazurkiewicz M; Wasiutyński A Pol Merkur Lekarski; 2007 Jun; 22(132):509-13. PubMed ID: 17874618 [TBL] [Abstract][Full Text] [Related]
39. Three-decade investigation of familial pheochromocytoma. An allele of von Hippel-Lindau disease? Tisherman SE; Tisherman BG; Tisherman SA; Dunmire S; Levey GS; Mulvihill JJ Arch Intern Med; 1993 Nov; 153(22):2550-6. PubMed ID: 8239848 [TBL] [Abstract][Full Text] [Related]
40. Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. Welander J; Söderkvist P; Gimm O Endocr Relat Cancer; 2011 Dec; 18(6):R253-76. PubMed ID: 22041710 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]